VCs remain confident alternative protein has a real future despite public-market woes How well have alternative-protein companies done in the past year? It depends on...

6 investors explain why they are bullish about Japan’s startup scene despite an uncertain economy Thinking of Japan often evokes notions of bleeding-edge tech mixed...

Profitability over growth: 5 investors explain their mantra for South Korean startups South Korea’s economic model has for decades leaned on export-led manufacturing operated by...

For startups, how many clouds to use may be the wrong question to ask Should early-stage startups pursue a single-cloud, multicloud or on-prem strategy when...

The new rules of venture debt are already being written The collapse of Silicon Valley Bank (SVB) was not the end of venture debt, but...

5 investors discuss what’s in store for venture debt following SVB’s collapse There are many questions around the implications of Silicon Valley Bank’s (SVB) collapse...

11 investors predict a colorful, if difficult, future for psychedelic startups How far has the psychedelics medicines industry come over the past 12 months? Well,...

Four investors explain why AI ethics can’t be an afterthought Billions of dollars are flooding into AI. Yet, AI models are already being affected by...

13 VCs talk about the state of robotics investing in 2023 Robotics is a fascinating topic. It can be frustrating, too. When I started covering...

6 VCs explain why embedded insurance isn’t the only hot opportunity in insurtech If you think embedded insurance is the only hot thing in insurtech...